Poseida Therapeutics Inc (PSTX)
2.535
+0.06
(+2.63%)
USD |
NASDAQ |
Nov 04, 16:00
2.535
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Price: 2.535 for Nov. 4, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 01, 2024 | 2.40 | 2.48 | 2.39 | 2.47 | 255645.0 |
Oct 31, 2024 | 2.39 | 2.39 | 2.32 | 2.37 | 266784.0 |
Oct 30, 2024 | 2.45 | 2.475 | 2.375 | 2.38 | 398390.0 |
Oct 29, 2024 | 2.48 | 2.485 | 2.38 | 2.45 | 513343.0 |
Oct 28, 2024 | 2.44 | 2.51 | 2.43 | 2.48 | 338022.0 |
Oct 25, 2024 | 2.42 | 2.489 | 2.40 | 2.41 | 225823.0 |
Oct 24, 2024 | 2.50 | 2.51 | 2.41 | 2.42 | 422572.0 |
Oct 23, 2024 | 2.48 | 2.51 | 2.440 | 2.50 | 442796.0 |
Oct 22, 2024 | 2.49 | 2.51 | 2.445 | 2.50 | 206810.0 |
Oct 21, 2024 | 2.45 | 2.52 | 2.41 | 2.50 | 394309.0 |
Oct 18, 2024 | 2.57 | 2.57 | 2.44 | 2.45 | 559011.0 |
Oct 17, 2024 | 2.55 | 2.61 | 2.465 | 2.54 | 658249.0 |
Oct 16, 2024 | 2.54 | 2.56 | 2.50 | 2.54 | 417826.0 |
Oct 15, 2024 | 2.49 | 2.57 | 2.475 | 2.54 | 689881.0 |
Oct 14, 2024 | 2.54 | 2.55 | 2.465 | 2.50 | 219991.0 |
Oct 11, 2024 | 2.48 | 2.51 | 2.445 | 2.51 | 332118.0 |
Oct 10, 2024 | 2.55 | 2.55 | 2.41 | 2.47 | 427808.0 |
Oct 09, 2024 | 2.57 | 2.605 | 2.51 | 2.56 | 468307.0 |
Oct 08, 2024 | 2.66 | 2.69 | 2.565 | 2.57 | 321910.0 |
Oct 07, 2024 | 2.62 | 2.67 | 2.50 | 2.66 | 440219.0 |
Oct 04, 2024 | 2.52 | 2.64 | 2.52 | 2.61 | 523986.0 |
Oct 03, 2024 | 2.65 | 2.65 | 2.50 | 2.54 | 538752.0 |
Oct 02, 2024 | 2.74 | 2.775 | 2.605 | 2.64 | 892109.0 |
Oct 01, 2024 | 2.82 | 2.86 | 2.730 | 2.75 | 350984.0 |
Sep 30, 2024 | 2.60 | 2.915 | 2.60 | 2.86 | 1.482M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.62
Minimum
Aug 03 2023
16.25
Maximum
Jul 20 2020
5.418
Average
4.01
Median
Price Benchmarks
MaxCyte Inc | 3.76 |
NovaBay Pharmaceuticals Inc | 0.78 |
Palatin Technologies Inc | 1.20 |
iBio Inc | 2.66 |
Theriva Biologics Inc | 2.08 |
Price Related Metrics
PS Ratio | 2.727 |
PEG Ratio | -0.0054 |
Price to Book Value | 4.049 |
Price to Free Cash Flow | 1137.93 |
Earnings Yield | -46.55% |
Market Cap | 246.23M |
PEGY Ratio | -0.0054 |